The human 60 kDa and microbial 65 kDa heat shock proteins (HSP) have been implicated in the pathogenesis of chronic periodontitis (CP) and coronary heart disease (CHD). We have studied 100 subjects: Group (a) consisted of patients with gingivitis (n = 25), group (b) were patients with CP (n = 25), group (c) patients with CHD and gingivitis (n = 25) and group (d) patients with CHD and CP (n = 25). PBMCs separated from peripheral blood were stimulated with medium, PMA/ionomycin, human HSP60, microbial HSP65, or no stimulus for 18 hours before intracellular IL-2, IFN-γ, TNF-α, IL-4, IL-5, or IL-17 were detected by flow cytometry. The mean fluorescence intensity (MFLI) for intracellular TNF-α was significantly increased when PBMC were stimulated with human HSP60 amongst the four groups (p = 0.001, ANOVA); pairwise comparisons revealed significant differences in MFLI between the gingivitis group and the CP (p = 0.017); between gingivitis and ging/CHD (p = 0.001) as well; but no significant difference between the CP and CP/CHD (p = 0.442). There was no significant difference in intracellular expression of IL-17, or any of the other cytokines tested; and the MFLI for HSP-stimulated were comparable to unstimulated cultures. When heat-labile human HSP60 was heated, intracellular cellular TNF-α expression was abrogated. In contrast, heat-stable LPS elicited TNF-α expression from monocytes in bulk cultures in all groups. These results suggest that the cytokine expression was dependent on human HSP60 and not LPS. Serum CRP was significantly associated with MFLI of intracellular TNF-α in CP patients (rs = 0.665, p = 0.026) and CP/CHD (rs = 0.699, p = 0.011). We conclude that human HSP60 elicits increased monocytic expression of TNF-α in patients with CP, CP/CHD or ging/CHD compared to patients with gingivitis. Since the marker of inflammation, namely CRP correlates with CP with or without CHD and not with mild chronic gingivitis or ging/CHD, this suggests that human HSP60-induced production of TNF-α is associated with CP and not CHD. There was no significant difference in intracellular expression of IL-17.
References
[1]
D. Locker, G. D. Slade and H. Murray, “Epidemiology of Periodontal Disease among Older Adults: A Review,” Periodontology 2000, Vol. 16, No. 1, 1998, pp. 16-33.
http://dx.doi.org/10.1111/j.1600-0757.1998.tb00113.x
[2]
P. S. Kumar, et al., “New Bacterial Species Associated with Chronic Periodontitis,” Journal of Dental Research, Vol. 82, No. 5, 2003, pp. 338-344.
http://dx.doi.org/10.1177/154405910308200503
[3]
M. A. Listgarten and P. M. Loomer, “Microbial Identification in the Management of Periodontal Diseases. A Systematic Review,” Annals of Periodontology, Vol. 8, No. 1, 2003, pp. 182-192.
http://dx.doi.org/10.1902/annals.2003.8.1.182
[4]
D. E. Lopatin, et al., “Humoral Immunity to Stress Proteins and Periodontal Disease,” Journal of Periodontology, Vol. 70, No. 10, 1999, pp. 1185-1193.
http://dx.doi.org/10.1902/jop.1999.70.10.1185
[5]
G. Schett, et al., “Salivary Anti-hsp65 Antibodies as a Diagnostic Marker for Gingivitis and a Possible Link to Atherosclerosis,” International Archives of Allergy and Immunology, Vol. 114, No. 3, 1997, pp. 246-250.
http://dx.doi.org/10.1159/000237675
[6]
C. A. Colaco, et al., “Heat Shock Proteins: Stimulators of Innate and Acquired Immunity,” BioMed Research International, Vol. 2013, 2013, p. 11.
[7]
K. Buhlin, et al., “Risk Factors for Cardiovascular Disease in Patients with Periodontitis,” European Heart Journal, Vol. 24, No. 23, 2003, pp. 2099-2107.
http://dx.doi.org/10.1016/j.ehj.2003.09.016
[8]
A. Hasan, et al., “The Immune Responses to Human and Microbial Heat Shock Proteins in Periodontal Disease with and without Coronary Heart Disease,” Clinical & Experimental Immunology, Vol. 142, No. 3, 2005, pp. 585-594.
[9]
K. Tabeta, et al., “Elevated Humoral Immune Response to Heat Shock Protein 60 (hsp60) Family in Periodontitis Patients,” Clinical & Experimental Immunology, Vol. 120, No. 2, 2000, pp. 285-293.
http://dx.doi.org/10.1046/j.1365-2249.2000.01216.x
[10]
I. Ishikawa, et al., “Induction of the Immune Response to Periodontopathic Bacteria and Its Role in the Pathogenesis of Periodontitis,” Periodontology 2000, Vol. 14, 1997, pp. 79-111.
http://dx.doi.org/10.1111/j.1600-0757.1997.tb00193.x
[11]
T. R. Mosmann, et al., “Two Types of Murine Helper T Cell Clone. I. Definition According to Profiles of Lymphokine Activities and Secreted Proteins,” Journal of Immunology, Vol. 136, No. 7, 1986, pp. 2348-2357.
[12]
E. Gemmell, K. Yamazaki, and G. J. Seymour, “Destructive Periodontitis Lesions Are Determined by the Nature of the Lymphocytic Response,” Critical Reviews in Oral Biology & Medicine, Vol. 13, No. 1, 2002, pp. 17-34.
http://dx.doi.org/10.1177/154411130201300104
[13]
J. W. Eastcott, et al., “Adoptive Transfer of Cloned T Helper Cells Ameliorates Periodontal Disease in Nude Rats,” Oral Microbiology and Immunology, Vol. 9, No. 5, 1994, pp. 284-289.
http://dx.doi.org/10.1111/j.1399-302X.1994.tb00072.x
[14]
M. A. Taubman and T. Kawai, “Involvement of T-Lymphocytes in Periodontal Disease and in Direct and Indirect Induction of Bone Resorption,” Critical Reviews in Oral Biology & Medicine, Vol. 12, No. 2, 2001, pp. 125-135.
http://dx.doi.org/10.1177/10454411010120020301
[15]
K. Yamashita, et al., “Effect of Adoptive Transfer of Cloned Actinobacillus Actinomycetemcomitans-Specific T Helper Cells on Periodontal Disease,” Infection and Immunity, Vol. 59, No. 4, 1991, pp. 1529-1534.
[16]
H. Yoshie, et al., “Periodontal Bone Loss and Immune Characteristics after Adoptive Transfer of Actinobacillus-Sensitized T Cells to Rats,” Journal of Periodontal Research, Vol. 22, No. 6, 1987, pp. 499-505.
http://dx.doi.org/10.1111/j.1600-0765.1987.tb02061.x
[17]
T. Aoyagi, et al., “Interleukin 4 (IL-4) and IL-6-Producing Memory T-Cells in Peripheral Blood and Gingival Tissue in Periodontitis Patients with High Serum Antibody Titers to Porphyromonas Gingivalis,” Oral Microbiology and Immunology, Vol. 10, No. 5, 1995, pp. 304- 310.
http://dx.doi.org/10.1111/j.1399-302X.1995.tb00159.x
[18]
Y. Tokoro, et al., “Relevance of Local Th2-Type Cytokine mRNA Expression in Immunocompetent Infiltrates in Inflamed Gingival Tissue to Periodontal Diseases,” Clinical & Experimental Immunology, Vol. 107, No. 1, 1997, pp. 166-174.
http://dx.doi.org/10.1046/j.1365-2249.1997.d01-880.x
[19]
K. Yamazaki, et al., “IL-4- and IL-6-Producing Cells in Human Periodontal Disease Tissue,” Journal of Oral Pathology & Medicine, Vol. 23, No. 8, 1994, pp. 347-353.
http://dx.doi.org/10.1111/j.1600-0714.1994.tb00074.x
[20]
A. Blaizot, et al., “Periodontal Diseases and Cardiovascular Events: Meta-Analysis of Observational Studies,” International Dental Journal, Vol. 59, No. 4, 2009, pp. 197-209.
[21]
J. Frostegard, “Immunity, Atherosclerosis and Cardiovascular Disease,” BMC Medicine, Vol. 11, 2013, p. 117.
http://dx.doi.org/10.1186/1741-7015-11-117
[22]
J. Frostegard, et al., “Cytokine Expression in Advanced Human Atherosclerotic Plaques: Dominance of Pro-Inflammatory (Th1) and Macrophage-Stimulating Cytokines,” Atherosclerosis, Vol. 145, No. 1, 1999, pp. 33-43.
http://dx.doi.org/10.1016/S0021-9150(99)00011-8
[23]
N. Gerdes, et al., “Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages: Implications for Atherogenesis,” Journal of Experimental Medicine, Vol. 195, No. 2, 2002, pp. 245-257.
http://dx.doi.org/10.1084/jem.20011022
[24]
Z. Mallat, et al., “Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability,” Circulation, Vol. 104, No. 14, 2001, pp. 1598-1603.
http://dx.doi.org/10.1161/hc3901.096721
[25]
G. K. Hansson, et al., “Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis,” Circulation Research, Vol. 91, No. 4, 2002, pp. 281-291.
http://dx.doi.org/10.1161/01.RES.0000029784.15893.10
[26]
K. Kato, et al., “Elevated Levels of Pro-Inflammatory Cytokines in Coronary Artery Thrombi,” International Journal of Cardiology, Vol. 70, No. 3, 1999, pp. 267-273.
http://dx.doi.org/10.1016/S0167-5273(99)00093-5
[27]
M. Suzuki, et al., “Relation of C-Reactive Protein and Interleukin-6 to Culprit Coronary Artery Plaque Size in Patients with Acute Myocardial Infarction,” American Journal of Cardiology, Vol. 91, No. 3, 2003, pp. 331-333.
http://dx.doi.org/10.1016/S0002-9149(02)03162-4
[28]
C. Habich, et al., “Different Heat Shock Protein 60 Species Share Pro-Inflammatory Activity but Not Binding Sites on Macrophages,” FEBS Letters, Vol. 533, No. 1-3, 2003, pp. 105-109.
http://dx.doi.org/10.1016/S0014-5793(02)03772-9
[29]
A. Kol, et al., “Cutting Edge: Heat Shock Protein (HSP) 60 Activates the Innate Immune Response: CD14 Is an Essential Receptor for HSP60 Activation of Mononuclear Cells,” Journal of Immunology, Vol. 164, No. 1, 2000, pp. 13-17.
[30]
K. Ohashi, et al., “Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex,” Journal of Immunology, Vol. 164, No. 2, 2000, pp. 558-561.
[31]
W. E. Peetermans, et al., “Mycobacterial 65-Kilodalton Heat Shock Protein Induces Tumor Necrosis Factor Alpha and Interleukin 6, Reactive Nitrogen Intermediates, and Toxoplasmastatic Activity in Murine Peritoneal Macrophages,” Infection and Immunity, Vol. 63, No. 9, 1995, pp. 3454-3458.
[32]
J. S. Friedland, R. J. Shattock and G. E. Griffin, “Phagocytosis of Mycobacterium tuberculosis or Particulate Stimuli by Human Monocytic Cells Induces Equivalent Monocyte Chemotactic Protein-1 Gene Expression,” Cytokine, Vol. 5, No. 2, 1993, pp. 150-156.
http://dx.doi.org/10.1016/1043-4666(93)90054-9
[33]
P. Launois, et al., “IL-6 Production in Response to Puri- fied Mycobacterial Heat-Shock Proteins and to Antigen 85 in Leprosy,” Cell Immunology, Vol. 148, No. 2, 1993, pp. 283-290. http://dx.doi.org/10.1006/cimm.1993.1112
[34]
L. M. Macht, et al., “Relationship between Disease Severity and Responses by Blood Mononuclear Cells from Patients with Rheumatoid Arthritis to Human Heat-Shock Protein 60,” Immunology, Vol. 99, No. 2, 2000, pp. 208-214.
http://dx.doi.org/10.1046/j.1365-2567.2000.00966.x
[35]
K. Yamazaki, et al., “Accumulation of Human Heat Shock Protein 60-Reactive T Cells in the Gingival Tissues of Periodontitis Patients,” Infection and Immunity, Vol. 70, No. 5, 2002, pp. 2492-2501.
http://dx.doi.org/10.1128/IAI.70.5.2492-2501.2002
[36]
S. Taleb, A. Tedgui and Z. Mallat, “Interleukin-17: Friend or Foe in Atherosclerosis?” Current Opinion in Lipidology, Vol. 21, No. 5, 2010, pp. 404-408.
http://dx.doi.org/10.1097/MOL.0b013e32833dc7f9
[37]
C. Prussin and D. D. Metcalfe, “Detection of Intracytoplasmic Cytokine Using Flow Cytometry and Directly Conjugated Anti-Cytokine Antibodies,” Journal of Immunological Methods, Vol. 188, No. 1, 1995, pp. 117-128.
http://dx.doi.org/10.1016/0022-1759(95)00209-X
[38]
E. D. Rossmann, et al., “Intracellular T Cell Cytokines in Patients with B Cell Chronic Lymphocytic Leukaemia (B-CLL),” European Journal of Haematology, Vol. 68, No. 5, 2002, pp. 299-306.
http://dx.doi.org/10.1034/j.1600-0609.2002.01612.x
[39]
E. M. Caraher, et al., “Flow Cytometric Analysis of Intracellular IFN-Gamma, IL-4 and IL-10 in CD3(+)4(+) T-Cells from Rat Spleen,” Journal of Immunological Methods, Vol. 244, No. 1-2, 2000, pp. 29-40.
http://dx.doi.org/10.1016/S0022-1759(00)00249-0
[40]
B. Sander, et al., “Similar Frequencies and Kinetics of Cytokine Producing Cells in Murine Peripheral Blood and Spleen. Cytokine Detection by Immunoassay and Intracellular Immunostaining,” Journal of Immunological Methods, Vol. 166, No. 2, 1993, pp. 201-214.
http://dx.doi.org/10.1016/0022-1759(93)90361-A
[41]
I. M. Chalmers, et al., “Intracellular Cytokine Profile of Cord and Adult Blood Lymphocytes,” Blood, Vol. 92, No. 1, 1998, pp. 11-18.
[42]
K. Ueki, et al., “Self-Heat Shock Protein 60 Induces Tumour Necrosis Factor-Alpha in Monocyte-Derived Macrophage: Possible Role in Chronic Inflammatory Periodontal Disease,” Clinical & Experimental Immunology, Vol. 127, No. 1, 2002, pp. 72-77.
http://dx.doi.org/10.1046/j.1365-2249.2002.01723.x
[43]
H. de Jong, et al., “Pan-DR-Binding Hsp60 Self Epitopes Induce an Interleukin-10-Mediated Immune Response in Rheumatoid Arthritis,” Arthritis & Rheumatism, Vol. 60, No. 7, 2009, pp. 1966-1976.
http://dx.doi.org/10.1002/art.24656
[44]
G. Almanzar, et al., “Autoreactive HSP60 Epitope-Specific T-Cells in Early Human Atherosclerotic Lesions,” Journal of Autoimmunity, Vol. 39, No. 4, 2012, pp. 441- 450. http://dx.doi.org/10.1016/j.jaut.2012.07.006
[45]
K. Tabeta, et al., “Toll-Like Receptors Confer Responsiveness to Lipopolysaccharide from Porphyromonas Gingivalis in Human Gingival Fibroblasts,” Infection and Immunity, Vol. 68, No. 6, 2000, pp. 3731-3735.
http://dx.doi.org/10.1128/IAI.68.6.3731-3735.2000
[46]
J. M. Ramage, et al., “T Cell Responses to Heat-Shock Protein 60: Differential Responses by CD4+ T Cell Subsets According to Their Expression of CD45 Isotypes,” Journal of Immunology, Vol. 162, No. 2, 1999, pp. 704- 710.
[47]
P. P. Hujoel, et al., “Periodontal Disease and Coronary Heart Disease Risk,” JAMA, Vol. 284, No. 11, 2000, pp. 1406-1410. http://dx.doi.org/10.1001/jama.284.11.1406
[48]
M. I. Ryder, et al., “Effects of Tobacco Smoke on the Secretion of Interleukin-1beta, Tumor Necrosis Factor- Alpha, and Transforming Growth Factor-Beta from Peripheral Blood Mononuclear Cells,” Oral Microbiology and Immunology, Vol. 17, No. 6, 2002, pp. 331-336.
http://dx.doi.org/10.1034/j.1399-302X.2002.170601.x
[49]
E. Yamaguchi, et al., “Release of Tumor Necrosis Factor- Alpha from Human Alveolar Macrophages Is Decreased in Smokers,” Chest, Vol. 103, No. 2, 1993, pp. 479-483.
http://dx.doi.org/10.1378/chest.103.2.479
[50]
Y. Iwamoto, et al., “Antimicrobial Periodontal Treatment Decreases Serum C-Reactive Protein, Tumor Necrosis Factor-Alpha, but Not Adiponectin Levels in Patients with Chronic Periodontitis,” Journal of Periodontology, Vol. 74, No. 8, 2003, pp. 1231-1236.
http://dx.doi.org/10.1902/jop.2003.74.8.1231
